MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 235 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $84,639 | -28.1% | 11,821 | -12.9% | 0.00% | – |
| Q1 2024 | $117,704 | +71.1% | 13,576 | +29.3% | 0.00% | – |
| Q4 2023 | $68,795 | -35.4% | 10,503 | -1.3% | 0.00% | – |
| Q3 2023 | $106,420 | -7.6% | 10,642 | +14.9% | 0.00% | – |
| Q2 2023 | $115,126 | -6.9% | 9,262 | +5.0% | 0.00% | – |
| Q1 2023 | $123,610 | +19.9% | 8,823 | +22.5% | 0.00% | – |
| Q4 2022 | $103,062 | +10206.2% | 7,202 | +11706.6% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 61 | -15.3% | 0.00% | – |
| Q2 2022 | $3,000 | -62.5% | 72 | -69.7% | 0.00% | – |
| Q1 2022 | $8,000 | +100.0% | 238 | +153.2% | 0.00% | – |
| Q4 2021 | $4,000 | -50.0% | 94 | -48.4% | 0.00% | – |
| Q3 2021 | $8,000 | +60.0% | 182 | +43.3% | 0.00% | – |
| Q2 2021 | $5,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |